Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER versus SODIUM SUCCINATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM CHLORIDE 10 IN PLASTIC CONTAINER versus SODIUM SUCCINATE.
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER vs SODIUM SUCCINATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium ion is essential for normal cell function, including muscle contraction, nerve transmission, and blood coagulation. It acts as a positive inotrope by increasing myocardial contractility and also corrects hypocalcemia.
Sodium succinate is a salt of succinic acid, which serves as an intermediate in the tricarboxylic acid (TCA) cycle. It acts as a metabolic supplement, enhancing cellular respiration and energy production by providing substrate for the TCA cycle. It also exhibits antioxidant properties by scavenging free radicals.
IV: 500 mg to 1 g (5-10 mL of 10% solution) administered slowly at a rate not exceeding 0.5-1 mL/min. May be repeated as needed based on serum calcium levels and clinical response.
No established standard dosing for sodium succinate as a therapeutic agent; it is used as a pharmaceutical excipient or buffering agent in intravenous formulations. For buffering purposes, typical concentrations range from 0.5% to 2% in injection solutions, administered intravenously at rates adjusted per clinical need.
None Documented
None Documented
2-4 hours in patients with normal renal function; prolonged in renal impairment.
5-10 minutes; rapid elimination limits systemic effects.
Primarily renal (80-90% as ionized calcium); minor fecal elimination (<10%).
Renal excretion of unchanged drug; less than 5% biliary/fecal.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement